Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @PaganoniMDPhD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PaganoniMDPhD
-
Prikvačeni tweet
Great way to start 2020!
#ALS#MND@MGHNeurology The Healey for ALS at Mass General, in partnership with TackleALS and@NEALSConsortium, is leading the first Platform Trial for ALS- less placebo, more options, more drugs tested -> goal is to accelerate the path to ALS treatmentshttps://twitter.com/MGHNeurology/status/1208129972910485504 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
You can read here a summary of our "Innate Immune Hypothesis of Alzheimer's Disease" connecting infection and genetic risk factors as the causes of Alzheimer's diseasehttps://twitter.com/MGHNeuroSci/status/1225083744840630272 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
There is not a red state version of ALS and a blue state version of ALS. There is only ALS. There is not a pro-ALS group and anti-ALS group, there is 1 movement to end ALS. We speak with different words but seek the same future. We fight for each other and will be the cure.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Have you heard about the AAP's new
#Mentoring Program? Matching is now open! Mentees, sign in now to select your top#physiatry mentor - it's first come, first served so act fast. Not involved? Learn more and sign up! http://www.physiatry.org/mentoring pic.twitter.com/hFGWwFMfpo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Hard work & dedication have helped Dr. Deborah Venesy become
#AAPMR's Vice President. She is an amazing example of the power of#WomenInMedicine. Read more from Dr. Venesy and other inspirational female#physiatrists at http://ow.ly/d9Ez50yaw2s .
#NationalWomenPhysiciansDaypic.twitter.com/RhpotSKvAP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
2/ "It is through these collective efforts that we are creating a platform for scientific inquiry that can lead to breakthrough discoveries." -Dr. Hemali Phatnani. VIDEO PART 2
#ALSresearch#Collaborationpic.twitter.com/61yj0YaZIJPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
1/ "To date, over 3,000 genomic and clinically annotated samples from
#ALS patients have been sequenced and analyzed, and this dataset, one of the largest cohorts in the world, is available to all researchers." -Dr. Hemali Phatnani VIDEO PART 1#ALSresearch#Collaborationpic.twitter.com/knoCs4EVe5Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Did you know it's National
#PatientRecognitionWeek ? Read about neuromuscular disease patient Hattie McBride's journey here! https://www.neuromuscularfoundation.org/News-Express/Hattie%E2%80%99s-World-with-SMA-Donuts,-Dinosaurs,-and-Do …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis - read this 2019 Top Accessed article in Muscle and Nerve
#BestofNeuro2019#openaccess@AANEMorg@MuscleAndNerve http://ow.ly/XShA30q9anq pic.twitter.com/jFO1uPTM0M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
FDA Gives OK to HEALEY
#ALS Platform Trial Testing Zilucoplan, CNM-Au8, and Verdiperstat.@alsnewstoday covers trial co-led by#MassGeneral investigator Sabrina Paganoni, MD.@PaganoniMDPhDhttp://ow.ly/BsOX50y75duHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Merit Cudkowicz, MD, MSc, Director of the Healey Center for ALS, discusses the impact of the “May Proceed” notice from the FDA for three drugs in first ALS platform trial
@meritcudkowicz@PaganoniMdPhD https://youtu.be/IYnoPLqFdRM via@YouTubeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
The FDA has approved to proceed with administering three proposed drug regimens in the HEALEY ALS Platform Trial. The
@ALSCenterWashU is a part of this platform. For more information, check out:https://www.massgeneral.org/neurology/als/news/2020-01-22-Healey-ALS-platform-trial-may-proceed …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Is there an association between mild cognitive impairment, social engagement, and mobility? Dr.
@HannahSteereMD and her team share their findings http://ow.ly/qPv650y37x3#Physiatry#CognitiveRehab#CognitiveImpairment#Rehab@VABostonHC@SpauldingRehab@harvardmedpic.twitter.com/mb1QM62pFG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
#1YearHighlight When@bsw5020 took our fight to Congress and showed us each that we have the power to change the world.https://twitter.com/iamalsorg/status/1115774890827755520 …
1:31Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Amazing news in
#ALS today! Very excited for the platform trial and the hard work by@MGHNeurology and@PaganoniMDPhD making this highly efficient trial possible!https://twitter.com/MGHNeurology/status/1220014534896676864 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
We are excited to announce the FDA’s clearance of the IND application for the HEALEY
#ALS Platform Trial, led by the Sean M. Healey & AMG Center at@MassGeneralNews. To learn more:https://bit.ly/2veqQ0HHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
#MGH's Healey Center and its collaborators are one step closer to accelerating therapies for people with#ALS. Read the full press release here. https://bit.ly/2Gg1cuC pic.twitter.com/QU8GnifxRv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
The Healey Center for ALS has received approval from the U.S. Food & Drug Administration (FDA) to proceed w/administering 3 proposed drug regimens in the HEALEY ALS Platform Trial – the first trial of its kind for ALS.
@MeritCudkowicz@PaganoniMDPhD@GSVLab@sheenachew@bsw5020https://twitter.com/MassGeneralNews/status/1220013751908233216 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
What a week for the ALS community! 1 Congressional Gold Medal. 11 meetings with 29 congressional leaders. 100 House ALS Caucus members strong. 30+ media outlets talking about
#ALS. 1 collective community out to change the world. https://www.instagram.com/p/B7bisYsHPXb/?utm_source=ig_web_copy_link …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Congratulations to our friend and volunteer leader,
@MVGutierrezMD on her new role@UTHealthSA ! We're sure that#physiatry@UTHealthSA will be in good, capable hands!#MemberInTheNewshttps://twitter.com/CCollinsPhD/status/1217899139167674370 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sabrina Paganoni, MD, PhD proslijedio/la je Tweet
Hot off the Press!! Congrats to Dr. Mónica Verduzco-Gutierrez (
@MVGutierrezMD), an accomplished Physiatrist, recently named PM&R Chair@UTHealthSA Long School of Medicine!!
Look forward to working with you! @WomenInPMR@LatinasInMed@NHMAmd#WomeninMedicine@ELAMProgrampic.twitter.com/m4Jvjbfr3S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.